Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 10-2012 | 07-2012 | 04-2012 | 01-2012 | 10-2011 | |
| Sales | 25,630 | 26,408 | 25,949 | 24,973 | 25,753 |
| Cost of Goods | 13,894 | 14,735 | 13,893 | 13,394 | 13,951 |
| Gross Profit | 11,736 | 11,673 | 12,056 | 11,579 | 11,802 |
| Operating Expenses | 16,614 | 41,200 | 16,471 | 15,776 | 17,115 |
| Operating Income | -3,984 | -28,792 | -3,522 | -3,803 | -4,362 |
| Other Income | 229 | -282 | 77 | -273 | 36 |
| Pre-tax Income | -3,755 | -29,074 | -3,445 | -4,076 | -4,326 |
| Income Tax | -64 | -1,931 | -34 | 145 | 168 |
| Net Income Continuous | -3,691 | -27,143 | -3,411 | -4,221 | -4,494 |
| Net Income | $-3,691 | $-27,143 | $-3,411 | $-4,221 | $-4,494 |
| EPS Basic Total Ops | -0.09 | -0.69 | -0.09 | -0.11 | -0.12 |
| EPS Basic Continuous Ops | -0.09 | -0.70 | -0.09 | -0.11 | -0.12 |
| EPS Diluted Total Ops | -0.09 | -0.69 | -0.09 | -0.11 | -0.12 |
| EPS Diluted Continuous Ops | -0.09 | -0.70 | -0.09 | -0.11 | -0.12 |
| EBITDA(a) | $-2,835 | $-27,601 | $-2,495 | $-2,766 | $-3,140 |